REAP Financial Group’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$255K Hold
936
– – 0.04% 114
2026
Q2
$232K Sell
936
-18
-2% -$3.88K 0.04% 121
2026
Q1
$192K Sell
954
-23
-2% -$4.76K 0.04% 133
2025
Q4
$202K Sell
977
-136
-12% -$27.2K 0.04% 126
2025
Q3
$200K Buy
1,113
+133
+14% +$22.6K 0.04% 113
2025
Q2
$158K Hold
980
– – 0.04% 132
2025
Q1
$167K Hold
980
– – 0.04% 110
2024
Q4
$163K Buy
980
+400
+69% +$68.3K 0.04% 123
2024
Q3
$100K Sell
580
-379
-40% -$62.7K 0.02% 159
2024
Q2
$148K Sell
959
-442
-32% -$66.3K 0.04% 135
2024
Q1
$215K Sell
1,401
-21
-1% -$3.2K 0.06% 120
2023
Q4
$225K Buy
+1,422
New +$204K 0.07% 126

Other funds holding FBT

REAP Financial Group's FBT Position: Q3 2026 in Review

REAP Financial Group held its First Trust NYSE Arca Biotechnology Index Fund (FBT) position steady in Q3 2026 at 936 shares worth $255K. The position accounts for 0.04% of the portfolio, ranked #114.

REAP Financial Group first reported a position in FBT in Q4 2023 and has held it in 12 quarters since. 311 funds tracked by Wall St. Rank hold FBT as of Q3 2026.

  • REAP Financial Group held 936 shares of First Trust NYSE Arca Biotechnology Index Fund worth $255K as of Q3 2026.
  • REAP Financial Group left its First Trust NYSE Arca Biotechnology Index Fund share count unchanged in Q3 2026.
  • First Trust NYSE Arca Biotechnology Index Fund made up 0.04% of REAP Financial Group's portfolio in Q3 2026, its #114 holding.
  • REAP Financial Group first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q4 2023 and has held it in 12 quarters since.
  • 311 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q3 2026.

Based on REAP Financial Group's 13F filing for Q3 2026, filed 2 Nov 2026.